Navigation Links
Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
Date:4/9/2008

ion Center

Preclinical data providing new details on SNS-314's anti-tumor activity will be presented Wednesday, April 16, 2008. SNS-314, a potent and selective pan-Aurora kinase inhibitor, is being studied in a Phase 1 dose-escalating clinical trial in patients with advanced solid tumors.

SNS-314 Poster Presentation

Wednesday, April 16, 2008

-- SNS-314, a potent inhibitor of Aurora kinases, has preclinical

anti-activity and induces apoptosis

Session: Heat Shock Protein Inhibitors, Aurora Kinase and other Mitotic

Inhibitors

Abstract #5648

8:00 a.m. - 12:00 p.m. Exhibit Hall B-F, San Diego Convention Center

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
2. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
3. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
4. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
5. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
6. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
7. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
8. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
9. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
10. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
11. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 The global insulin market ... a new study by Grand View Research, Inc. Growing global prevalence ... high unmet needs in emerging markets such as India ... be two of the most significant growth drivers of this market. ... and growing global geriatric population base are expected to serve the ...
(Date:6/29/2015)... 29, 2015  VisionCare Ophthalmic Technologies, Inc. ... devices for the treatment of age-related macular ... "Long-Term (60-month) Results for the Implantable Miniature ... Age in Patients with End-Stage Age-Related Macular ... 5-year data show substantial retention of gains ...
(Date:6/29/2015)... Corporates today are on the ... CSR funds effectively.  A genuine step towards improving the ... would definitely interest them. And to make this possible, ... (MSC) to promote experiential learning.  STEM Learning is a ... India . So far, they have ...
Breaking Medicine Technology:Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 2Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 3Insulin Market To Reach $47.54 Billion By 2020: Grand View Research, Inc. 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5Thinking of Innovative CSR Options? Partner With STEM Learning to Sponsor a Mini Science Centre 2Thinking of Innovative CSR Options? Partner With STEM Learning to Sponsor a Mini Science Centre 3
... $500 Million Senior Notes Offering in Connection With Agreement to... -- ARDEE, Ireland, Sept. 24 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... 24 Stereotaxis, Inc. (Nasdaq: STXS ) today ... JMP Securities Healthcare Conference on Tuesday, September 28, 2010 at ... Officer, will provide an overview of the Company,s business strategy ... conference is by invitation only. A live audio and slides ...
Cached Medicine Technology:Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 8Warner Chilcott Announces $500 Million Senior Notes Offering in Connection With Agreement to Acquire U.S. Rights to Enablex® 9Stereotaxis to Present at the JMP Securities Healthcare Conference 2Stereotaxis to Present at the JMP Securities Healthcare Conference 3
(Date:6/29/2015)... ... June 29, 2015 , ... Scientists from the ... build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping. The ... their association with human disease, but previously difficult to detect. The study was ...
(Date:6/29/2015)... ... June 29, 2015 , ... USA Today reported on ... Dakota, Arkansas, and Alabama. To impact the rest of the nation’s growing overdose death ... suggested the following guidelines be followed to stop the increasing overdose trend from continuing: ...
(Date:6/29/2015)... ... June 29, 2015 , ... New research ... fewer than 10 percent of U.S. state and local governments have implemented Next ... implementation deadline for NG9-1-1. , “Mobile phones have surpassed land lines as ...
(Date:6/29/2015)... ... June 29, 2015 , ... FACE is proud to be one ... the reduction of the double chin and redefining of the jawline. Excess fat ... much older and heavier causing the person distress and poor self-image. , Kybella was ...
(Date:6/29/2015)... , ... June 29, 2015 , ... Care to Care, ... to Care. , Dr. Faber will lead the Radiation Oncology Services Program, with a ... the use of Care to Care’s proprietary evidence based criteria. He will assist ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Overdose Death Rates Decreased in Florida as of 2015 2Health News:Overdose Death Rates Decreased in Florida as of 2015 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4Health News:FACE Detroit Skin and Wellness Clinic Introduces Newly FDA Approved Kybella for the elimination of the Double Chin. 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 3
... aerated beverages, yoga exponent Ramdev today asked the Centre ... that a statutory warning be written on every bottle ... a statutory warning should be written on every bottle ... infertility and diabetes,' he told reporters here., ,He ...
... Composite Laboratory at Kandaghat has not been functioning for over a ... since the former official for drug analyzing retired a month ago, ... his place. The number of samples awaiting testing at the laboratory ... Wasuja retired on April 30 after 38 years of service. With ...
... Goa, has suggested that the phar produce medicines which ... // He made this suggestion after inaugurating the new ... days ago. ,He also added that modern medicines and ... it was, therefore, essential that in the field of health ...
... High Court today held that medical colleges should give ... got caste validity certificate despite applying for the same. ... submit the certificate within 90 days of the admission, ... quotas, a candidate has to provide a caste certificate ...
... Australia could be receiving food supplements to improve their behaviour ... it is still investigating the feasibility of doing so. ... Department would review the British study, which claimed that children ... of Omega 3 fish oil. ,"The focus in ...
... Ramadoss Wednesday assured representatives of the civil society ... bring amendments in the legislation concerned to prevent ... willing to bring further amendments in the Preconception ... Act for stricter enforcement of the legislation," Ramadoss ...
Cached Medicine News:Health News:Working of Drug Department on Hold Without Drug Analyst 2
... by seeing more patients per day. Utilizing the ... a 14-18 patients per day practice into a ... test sequences, youll perform accurate refractions in less ... making it easy to delegate tasks to office ...
... web-based application for secure access to ... reporting system. It is highly user ... comprehensive analysis, and professional reporting from ... with HIPAA requirements, reports also include ...
... Nothing can be more frustrating to a ... section of tissue than using instruments that are ... simple, or more complex, we offer a wide ... From realigning and polishing the tips to standard ...
... We repair most Olympus fiber and ... and intubation scopes used in OR and ... all repairs meet or exceed the standards ... with a 120-day warranty against defects in ...
Medicine Products: